Skip to content

Clinical trials

Angina, Stable trials with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Angina, Stable Phase: Not applicable Clear all

127 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20042
20051
20063
20072
20091
20104
20114
20128
20137
20146
20156
201613
20178
20183
201910
202011
20219
20223
20238
20246
20254
20268

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed67
Unknown status24
Recruiting14
Not yet recruiting8
Active, not recruiting7
Terminated5
Enrolling by invitation1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Imperial College London4
UMC Utrecht4
CID - Carbostent & Implantable Devices3
Laval University3
NHS National Waiting Times Centre Board3
Shiraz University of Medical Sciences3
An-Najah National University2
Biosensors Europe SA2
CeloNova BioSciences, Inc.2
Maastricht University Medical Center2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Angina, Stable127
Coronary Artery Disease49
Angina, Unstable35
Angina Pectoris20
Acute Coronary Syndrome15
Myocardial Ischemia15
Myocardial Infarction14
Non-ST Elevated Myocardial Infarction13
Chest Pain8
Coronary Disease8

Trials

Showing 76 to 100 of 127. Each trial links to its page on Pharma Observatory.

27 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.